Worldwide, marijuana (cannabis) is a widely used drug. The incidence of marijuana smoking is increasing and is second only to tobacco as the most widely smoked substance in the general population. It is also the second most commonly used recreational drug after alcohol. Some adverse effects of marijuana smoking have been documented; however, the number of studies on the pulmonary effects of marijuana in individuals with leukemia is limited. In our case series, we report on 2 men with acute myeloid leukemia with miliary nodular lung patterns on computed tomography of the chest due to heavy marijuana use. We also report on 2 patients with acute lymphocytic leukemia who had a history of smoking marijuana and then developed lung opacities consistent with mold infection.
MehmedicZ., ChandraS., SladeD.Potency trends of δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008.J Forensic Sci.2010; 55(5): 1209–1217.
9.
GillA.Bong lung: regular smokers of cannabis show relatively distinctive histologic changes that predispose to pneumothorax.Am J Surg Pathol.2005; 29(7): 980–982.
10.
AldingtonS., WilliamsM., NowitzM.Effects of cannabis on pulmonary structure, function and symptoms.Thorax.2007; 62(12): 1058–1063.
11.
JohnsonM.K., SmithR.P., MorrisonD.Large lung bullae in marijuana smokers.Thorax.2000; 55(4): 340–342.
12.
HiiS.W., TamJ.D., ThompsonB.R.Bullous lung disease due to marijuana.Respirology.2008; 13(1): 122–127.
13.
TashkinD P.. Airway effects of marijuana, cocaine, and other inhaled illicit agents.Curr Opin Pulm Med.2001; 7(2): 43–61.
MillerW.E., SpiekermanR.E., HepperN.G.Pneumomediastinum resulting from performing Valsalva maneuvers during marihuana smoking.Chest.1972; 62(2): 233–234.
16.
PhanT.D., LauK.K., LiX.Lung bullae and pulmonary fibrosis associated with marijuana smoking.Australas Radiol.2005; 49(5): 411–414.
17.
TanW.C., LoC., JongA.Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group. Marijuana and chronic obstructive lung disease: a population-based study.CMAJ.2009; 180(8): 814–820.
18.
FeldmanA.L., SullivanJ.T., PasseroM.A.Pneumothorax in poly-substance-abusing marijuana and tobacco smokers: three cases.J Subst Abuse.1993; 5(2): 183–186.
19.
KagenS.L.Aspergillosis: an inhalable contaminant of marijuana.N Engl J Med.1981; 304(8): 483–484.
20.
RuchlemerR., Amit-KohnM., RavehD.Inhaled medicinal cannabis and the immunocompromised patient.Support Care Cancer.2015; 23(3): 819–822.
VersteegP.A., SlotD.E., van der VeldenU.Effect of cannabis usage on the oral environment: a review.Int J Dent Hyg.2008; 6(4): 315–320.
23.
CoffmanK.L.The debate about marijuana usage in transplant candidates: recent medical evidence on marijuana health effects.Curr Opin Organ Transplant.2008; 13(2): 189–195.
24.
FisherB.A., GhuranA., VadamalaiV.Cardiovascular complications induced by cannabis smoking: a case report and review of the literature.Emerg Med J.2005; 22(9): 679–680.
TennstedtD., Saint-RemyA.Cannabis and skin diseases.Eur J Dermatol.2011; 21(1): 5–11.
33.
SolowijN., StephensR., RoffmanR.A.Does marijuana use cause long-term cognitive deficits?JAMA.2002; 287: 2653–2654.
34.
McHaleS., HuntN.Executive function deficits in short-term abstinent cannabis users.Hum Psychopharmacol.2008; 23(5): 409–415.
35.
AldingtonS., HarwoodM., CoxB.Cannabis use and risk of lung cancer: a case-control study.Eur Respir J.2008; 31(2): 280–286.
36.
MehraR., MooreB.A., CrothersK.The association between marijuana smoking and lung cancer: a systematic review.Arch Intern Med.2006; 166(13): 1359–1367.
37.
BerthillerJ., StraifK., BoniolM.Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb.J Thorac Oncol.2008; 3(12): 1398–1403.
38.
BrambillaC., ColonnaM.Cannabis: the next villain on the lung cancer battlefield?Eur Respir J.2008; 31(2): 227–228.
39.
CallaghanR.C., AllebeckP., SidorchukA.Marijuana use and risk of lung cancer: a 40-year cohort study.Cancer Causes Control.2013; 24(10): 1811–1820.
TramerM.R., CarrollD., CampbellF.A.Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.BMJ.2001; 323(7303): 16–21.
42.
SchwartzR.H., VothE.A., SheridanM.J.Marijuana to prevent nausea and vomiting in cancer patients: a survey of clinical oncologists.South Med J.1997; 90(2): 167–172.
43.
KondradE., ReidA.Colorado family physicians’ attitudes toward medical marijuana.J Am Board Fam Med.2013; 26(1): 52–60.
44.
HeynemanL.E., WardS., LynchDA. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process?Am J Roentgenol.1999; 173(6): 1617.
45.
BaldwinG.C., TashkinD.P., BuckleyD.M.Marijuana and cocaine impair alveolar macrophage function and cytokine production.Am J Respir Crit Care Med.1997; 156(5): 1606–1613.
46.
BerkowitzE.A., HenryT.S., VeeraraghavanS.Pulmonary effects of synthetic marijuana: chest radiography and CT findings.AJR Am J Roentgenol.2015; 204(4): 750–757.
47.
TetraultJ.M., CrothersK., MooreB.A.Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review.Arch Intern Med.2007; 167(3): 221–228.
48.
TashkinD.P., BaldwinG.C., SarafianT.Respiratory and Immunologic consequences of marijuana smoking.J Clin Pharmacol.2002; 42(11 suppl): 71S–81S.
49.
SipsasN.V., KontoyiannisD.P.Occupation, lifestyle, diet, and invasive fungal infections.Infection.2008: 36(6): 515–525.
50.
LibratyD.H., BocelliL., FraireA.Herpes simplex virus bronchiolitis in a cannabis user.IDCases.2013; 1(1): 2–4.
51.
ThuK., HayesM., MilesS.Marijuana ‘bong’ smoking and tuberculosis.Intern Med J.2013; 43(4): 456–458.
52.
GarganiY., BishopP., DenningD.W.Too many mouldy joints: marijuana and chronic pulmonary aspergillosis.Mediterr J Hematol Infect Dis.2011; 3(1): e2011005.
53.
VerweijP.E., KerremansJ.J., VossA.Fungal contamination of tobacco and marijuana.JAMA.2000; 284(22): 2875.
SuttonS., LumB.L., TortiF.M.Possible risk of invasive aspergillosis with marijuana use during chemotherapy for small cell lung cancer.Drug Intell Clin Pharm.1986; 20(4): 289–291.
57.
CesconD.W., PageA.V., RichardsonS.Invasive pulmonary aspergillosis with marijuana use in a man with colorectal cancer.J Clin Oncol.2008; 26(13): 2214–2215.
58.
Szyper-KravitzM., LangR., ManorY.Early invasive pulmonary aspergillosis in a leukemia patient linked to aspergillus contaminated marijuana smoking.Leuk Lymphoma.2001; 42(6): 1433–1437.
59.
HamadehR., ArdehaliA., LocksleyR.M.Fatal aspergillosis associated with smoking contaminated marijuana, in a marrow transplant recipient.Chest.1988; 94(2): 432–433.
60.
MarksW.H., FlorenceL., LiebermanJ.Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient.Transplantation.1996; 61(12): 1771–1774.
61.
De PauwB., WalshT.J., DonnellyJ.P.Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.Clin Infect Dis.2008; 46(12): 1813–1821.
62.
WalshT.J., AnaissieE.J., DenningD.W.Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.Clin Infect Dis.2008; 46(3): 327–360.
63.
GreeneR.E., SchlammH.T., OestmannJ.W.Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.Clin Infect Dis.2007; 44(3): 373–379.
64.
MarchioriE., MaromE.M., ZanettiG.Reversed halo sign in invasive fungal infections: criteria for differentiation from organizing pneumonia.Chest.2012; 142(6): 1469–1473.
65.
CumboT.A., SegalB.H.Prevention, diagnosis, and treatment of invasive fungal infections in patients with cancer and neutropenia.J Natl Compr Canc Netw.2004; 2(5): 455–69.
66.
Villafuerte-GutierrezP., VillalonL., LosaJ.E.Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update.Adv Hematol.2014; 2014: 986938.
67.
GlocknerA.Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin: review of the literature.Eur J Med Res.2011; 16(4): 167–179.
